Jane Street
COCP icon

Jane Street’s Cocrystal Pharma COCP Stock Holding History

Jane Street’s Portfolio COCP Stock Details COCP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$12.8K Buy
12,711
+2,085
+20% +$2.15K ﹤0.01% 11278
2025
Q4 		$10.4K Sell
10,626
-10,418
-50% -$11K ﹤0.01% 10834
2025
Q3 		$26.3K Buy
+21,044
New +$32.5K ﹤0.01% 10483
2022
Q3 		– Sell
-1,237
Closed -$6K – 9774
2022
Q2 		$6K Buy
+1,237
New +$6.59K ﹤0.01% 9389
2022
Q1 		– Sell
-1,097
Closed -$9K – 10363
2021
Q4 		$9K Buy
1,097
+173
+19% +$1.77K ﹤0.01% 9912
2021
Q3 		$12K Buy
+924
New +$12.2K ﹤0.01% 9797
2021
Q1 		– Sell
-965
Closed -$16K – 9132
2020
Q4 		$16K Sell
965
-2,457
-72% -$34.1K ﹤0.01% 7377
2020
Q3 		$38K Buy
+3,422
New +$62.4K ﹤0.01% 6958
2019
Q4 		– Sell
-898
Closed -$22K – 5114
2019
Q3 		$22K Sell
898
-8
-0.9% -$207 ﹤0.01% 4952
2019
Q2 		$26K Sell
906
-210
-19% -$6.24K ﹤0.01% 5006
2019
Q1 		$37K Sell
1,116
-118
-10% -$4.32K ﹤0.01% 4859
2018
Q4 		$53K Sell
1,234
-281
-19% -$9.27K ﹤0.01% 4719
2018
Q3 		$45K Sell
1,515
-272
-15% -$12.2K ﹤0.01% 4930
2018
Q2 		$78K Buy
+1,787
New +$66.3K ﹤0.01% 4773

Other funds holding COCP

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TC
T3 Companies New York $76.8M AUM
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Jane Street's COCP Position: Q1 2026 in Review

Jane Street increased its Cocrystal Pharma (COCP) stake by 20% in Q1 2026, buying an estimated $2.15K and bringing the position to 12,711 shares worth $12.8K. The position accounts for ﹤0.01% of the portfolio, ranked #11278.

Jane Street first reported a position in COCP in Q2 2018 and has held it in 14 quarters since. The position peaked at $78K in Q2 2018. 26 funds tracked by Wall St. Rank hold COCP as of Q1 2026.

  • Jane Street held 12,711 shares of Cocrystal Pharma worth $12.8K as of Q1 2026.
  • Jane Street bought 2,085 Cocrystal Pharma shares in Q1 2026, an estimated $2.15K.
  • Cocrystal Pharma made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #11278 holding.
  • Jane Street first reported a position in Cocrystal Pharma in Q2 2018 and has held it in 14 quarters since.
  • Jane Street's Cocrystal Pharma position peaked at $78K in Q2 2018.
  • 26 funds tracked by Wall St. Rank held Cocrystal Pharma as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.